Importance of N6‑methyladenosine RNA modification in lung cancer (Review)
- Authors:
- Yueyang Wang
- Xiaoming Su
- Mingyao Zhao
- Mingchen Xu
- Yueqi Chen
- Zhengyi Li
- Wenyue Zhuang
-
Affiliations: Department of Molecular Biology Test Technique, College of Medical Technology, Beihua University, Jilin 132000, P.R. China, Department of Clinical Examination Basis, Laboratory Academy, Jilin Medical University, Jilin 132000, P.R. China - Published online on: April 27, 2021 https://doi.org/10.3892/mco.2021.2290
- Article Number: 128
-
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Liu N and Pan T: N6-methyladenosine-encoded epitranscriptomics. Nat Struct Mol Biol. 23:98–102. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Jonkhout N, Tran J, Smith M, Schonrock N, Mattick J and Novoa E: The RNA modification landscape in human disease. RNA. 23:1754–1769. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Li L, Fan Y, Leng R, Pan H and Ye D: Potential link between m6A modification and systemic lupus erythematosus. Mol Immunol. 93:55–63. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Meyer K, Saletore Y, Zumbo P, Elemento O, Mason C and Jaffrey S: Comprehensive analysis of mRNA methylation reveals enrichment in 3'UTRs and near stop codons. Cell. 149:1635–1646. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Wang X, Lu Z, Gomez A, Hon G, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G, et al: N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 505:117–120. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Boccaletto P, Machnicka M, Purta E, Piatkowski P, Baginski B, Wirecki T, de Crécy-Lagard V, Ross R, Limbach P, Kotter A, et al: MODOMICS: A database of RNA modification pathways 2017 update. Nucleic Acids Res. 46:D303–D307. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Han Z, Niu T, Chang J, Lei X, Zhao M, Wang Q, Cheng W, Wang J, Feng Y and Chai J: Crystal structure of the FTO protein reveals basis for its substrate specificity. Nature. 464:1205–1209. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Shi H, Wang X, Lu Z, Zhao BS, Ma H, Hsu PJ, Liu C and He C: YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. 27:315–328. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Schumann U, Shafik A and Preiss T: METTL3 Gains R/W access to the Epitranscriptome. Mol Cell. 62:323–324. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, Jia G, Yu M, Lu Z, Deng X, et al: A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 10:93–95. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Wu F, Cheng W, Zhao F, Tang M, Diao Y and Xu R: Association of N6-methyladenosine with viruses and related diseases. Virol J. 16(133)2019.PubMed/NCBI | |
|
Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang W, Adhikari S, Shi Y, Lv Y, Chen YS, et al: Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 24:177–189. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Meyer K and Jaffrey S: Rethinking m6A Readers, Writers, and Erasers. Annu Rev Cell Dev Biol. 33:319–342. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Schwartz S, Mumbach M, Jovanovic M, Wang T, Maciag K, Bushkin G, Mertins P, Ter-Ovanesyan D, Habib N, Cacchiarelli D, et al: Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5'sites. Cell Rep. 8:284–296. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Ding Y, Qi N, Wang K, Huang Y, Liao J, Wang H, Tan A, Liu L, Zhang Z, Li J, et al: FTO facilitates lung adenocarcinoma cell progression by activating cell migration through mRNA Demethylation. Onco Targets Ther. 13:1461–1470. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhu Z, Qian Q, Zhao X, Ma L and Chen P: N 6-methyladenosine ALKBH5 promotes non-small cell lung cancer progress by regulating TIMP3 stability. Gene. 731(144348)2020.PubMed/NCBI View Article : Google Scholar | |
|
Han S, Tang Y and Smith R: Functional diversity of the hnRNPs: Past, present and perspectives. Biochem J. 430:379–392. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Patil D, Pickering B and Jaffrey S: Reading m 6 A in the Transcriptome: M 6 A-binding proteins. Trends Cell Biol. 28:113–127. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Müller S, Glaß M, Singh A, Haase J, Bley N, Fuchs T, Lederer M, Dahl A, Huang H, Chen J, et al: IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner. Nucleic Acids Res. 47:375–390. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Xu C, Liu K, Ahmed H, Loppnau P, Schapira M and Min J: Structural basis for the discriminative recognition of N6-methyladenosine RNA by the Human YT521-B homology domain family of proteins. J Biol Chem. 290:24902–24913. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Arguello A, DeLiberto A and Kleiner R: RNA chemical proteomics reveals the N 6-methyladenosine (m6A)-regulated protein-RNA Interactome. J Am Chem Soc. 139:17249–17252. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Edupuganti RR, Geiger S, Lindeboom RGH, Shi H, Hsu PJ, Lu ZY, Wang SY, Baltissen MPA, Jansen PWTC, Rossa M, et al: N 6-methyladenosine (m6A) recruits and repels proteins to regulate mRNA homeostasis. Nat Struct Mol Biol. 24:870–878. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Wu D, Li M, Tian W, Wang S, Cui L, Li H, Wang H, Ji A and Li Y: Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways. Sci Rep. 7(5134)2017.PubMed/NCBI View Article : Google Scholar | |
|
Wakelee H, Kelly K and Edelman M: 50 Years of progress in the systemic therapy of non-small cell lung cancer. Am Soc Clin Oncol Educ Book: 2014: 177-189 doi: 10.14694/EdBook_AM.2014.34.177. | |
|
Siegel R, Miller K and Jemal A: Cancer statistics, 2019. CA Cancer J Clin. 69:7–34. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Lin JJ, Cardarella S, Lydon CA, Dahlberg SE, Jackman DM, Jänne PA and Johnson BE: Five-year survival in EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs. J Thorac Oncol. 11:556–565. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Zhuang Z, Chen L, Mao Y, Zheng Q, Li H, Huang Y, Hu Z and Jin Y: Diagnostic, progressive and prognostic performance of m6A methylation RNA regulators in lung adenocarcinoma. Int J Biol Sci. 16:1785–1797. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen XY, Zhang J and Zhu JS: The role of m6A RNA methylation in human cancer. Mol Cancer. 18(103)2019.PubMed/NCBI View Article : Google Scholar | |
|
Liu Z, Li L, Sun H and Liu S: Link between m6A modification and cancers. Front Bioeng Biotechnol. 6(89)2018.PubMed/NCBI View Article : Google Scholar | |
|
Chen WW, Qi JW, Hang J, Wu JX, Zhou XX, Chen JZ, Wang J and Wang HH: Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA. Eur Rev Med Pharmacol Sci. 24:4263–4270. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, Di W, Hu B, An J, Kong L, et al: m(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. J Hematol Oncol. 12(135)2019.PubMed/NCBI View Article : Google Scholar | |
|
Choe J, Lin S, Zhang W, Liu Q, Wang L, Ramirez-Moya J, Du P, Kim W, Tang S, Sliz P, et al: mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis. Nature. 561:556–560. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Lin S, Choe J, Du P, Triboulet R and Gregory RI: The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 62:335–345. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Li X, Li N, Huang L, Xu S, Zheng X, Hamsath A, Zhang M, Dai L, Zhang H, Wong JJ, et al: Is hydrogen sulfide a concern during treatment of lung adenocarcinoma with ammonium tetrathiomolybdate? Front Oncol. 10(234)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wanna-Udom S, Terashima M, Lyu H, Ishimura A, Takino T, Sakari M, Tsukahara T and Suzuki T: The m6A methyltransferase METTL3 contributes to transforming growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB. Biochem Biophys Res Commun. 524:150–155. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Du Y, Hou G, Zhang H, Dou J, He J, Guo Y, Li L, Chen R, Wang Y, Deng R, et al: SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function. Nucleic Acids Res. 46:5195–5208. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Li L, Chang W and Hsiao M: Aberrant expression of microRNA clusters in head and neck cancer development and progression: Current and future translational impacts. Pharmaceuticals (Basel). 14(194)2021.PubMed/NCBI View Article : Google Scholar | |
|
Gu S, Sun D, Dai H and Zhang Z: N 6-methyladenosine mediates the cellular proliferation and apoptosis via microRNAs in Arsenite-transformed cells. Toxicol Lett. 292:1–11. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Du M, Zhang Y, Mao Y, Mou J, Zhao J, Xue Q, Wang D, Huang J, Gao S and Gao Y: MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA. Biochem Biophys Res Communs. 482:582–589. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Wei W, Huo B and Shi X: miR-600 inhibits lung cancer via downregulating the expression of METTL3. Cancer Manag Res. 11:1177–1187. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Wang H, Deng Q, Lv Z, Ling Y, Hou X, Chen Z, Dinglin X, Ma S, Li D, Wu Y, et al: N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1. Mol Cancer. 18(181)2019.PubMed/NCBI View Article : Google Scholar | |
|
Wu LS, Qian JY, Wang M and Yang H: Identifying the role of Wilms tumor 1 associated protein in cancer prediction using integrative genomic analyses. Mol Med Rep. 14:2823–2831. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Ruszkowska A, Ruszkowski M, Dauter Z and Brown J: Structural insights into the RNA methyltransferase domain of METTL16. Sci Rep. 8(5311)2018.PubMed/NCBI View Article : Google Scholar | |
|
Li N and Zhan X: Identification of pathology-specific regulators of m6A RNA modification to optimize lung cancer management in the context of predictive, preventive, and personalized medicine. EPMA J. 11:485–504. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Yang L, Ma Y, Han W, Li W, Cui L, Zhao X, Tian Y, Zhou Z, Wang W and Wang H: Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b. J Biol Chem. 290:26627–26637. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Li J, Han Y, Zhang H, Qian Z, Jia W, Gao Y, Zheng H and Li B: The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA. Biochem Biophys Res Commun. 512:479–485. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Liu J, Ren D, Du Z, Wang H, Zhang H and Jin Y: m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression. Biochem Biophys Res Commun. 502:456–464. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, Yi C, Lindahl T, Pan T, Yang YG and He C: N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 7:885–887. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Li F, Wang H, Huang H, Zhang L, Wang D and Wan Y: m6A RNA methylation regulators participate in the malignant progression and have clinical prognostic value in lung adenocarcinoma. Front Genet. 11(994)2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhao X, Yang Y, Sun BF, Shi Y, Yang X, Xiao W, Hao YJ, Ping XL, Chen YS, Wang WJ, et al: FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res. 24:1403–1419. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Chao Y, Shang J and Ji W: ALKBH5-m6A-FOXM1 signaling axis promotes proliferation and invasion of lung adenocarcinoma cells under intermittent hypoxia. Biochem Biophys Res Commun. 521:499–506. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Guo J, Wu Y, Du J, Yang L, Chen W, Gong K, Dai J, Miao S, Jin D and Xi S: Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression. Oncogenesis. 7(49)2018.PubMed/NCBI View Article : Google Scholar | |
|
Jin D, Guo J, Wu Y, Yang L, Wang X, Du J, Dai J, Chen W, Gong K, Miao S, et al: m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Mol Cancer. 19(40)2020.PubMed/NCBI View Article : Google Scholar | |
|
Deng X, Su R, Weng H, Huang H, Li Z and Chen J: RNA N(6)-methyladenosine modification in cancers: Current status and perspectives. Cell Res. 28:507–517. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Yue Y, Liu J and He C: RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 29:1343–1355. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Yang Y, Hsu PJ, Chen YS and Yang YG: Dynamic transcriptomic m(6)A decoration: Writers, erasers, readers and functions in RNA metabolism. Cell Res. 28:616–624. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Liu N, Dai Q, Zheng G, He C, Parisien M and Pan T: N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature. 518:560–564. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H and He C: N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell. 161:1388–1399. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Shi Y, Fan S, Wu M, Zuo Z, Li X, Jiang L, Shen Q, Xu P, Zeng L, Zhou Y, et al: YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression. Nat Commun. 10(4892)2019.PubMed/NCBI View Article : Google Scholar | |
|
Sheng H, Li Z, Su S, Sun W, Zhang X, Li L, Li J, Liu S, Lu B, Zhang S and Shan C: YTH domain family 2 promotes lung cancer cell growth by facilitating 6-phosphogluconate dehydrogenase mRNA translation. Carcinogenesis. 41:541–550. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Ma L, Chen T, Zhang X, Miao Y, Tian X, Yu K, Xu X, Niu Y, Guo S, Zhang C, et al: The m(6)A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function. Redox Biol. 38(101801)2021.PubMed/NCBI View Article : Google Scholar | |
|
Tauler J, Zudaire E, Liu H, Shih J and Mulshine J: hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines. Cancer Res. 70:7137–7147. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Wu C, Li W, Chen W, Xu D, Wei D and Zhou Q: Expression of hnRNP A2/B1 in human lung cancer cell lines. Chin J Lung Cancer. 7:121–124. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Dai X and Yang H: Cloning of hnRNP A2/B1 gene and detection of its expression in lung cancer tissues. Chin J Lung Cancer. 8:266–269. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Zhou J, Nong L, Wloch M, Cantor A, Mulshine J and Tockman M: Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. Lung Cancer. 34:341–350. 2001.PubMed/NCBI View Article : Google Scholar | |
|
He Y, Rothnagel J, Epis M, Leedman P and Smith R: Downstream targets of heterogeneous nuclear ribonucleoprotein A2 mediate cell proliferation. Mol Carcinog. 48:167–179. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Qu X, Liu J, Zhong X, Li X and Zhang Q: Insights into the roles of hnRNP A2/B1 and AXL in non-small cell lung cancer. Oncol Lett. 10:1677–1685. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Yu P, Kang A, Jing L and Wang Y: Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 22:993–1002. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Guo W, Huai Q, Zhang G, Guo L, Song P, Xue X, Tan F, Xue Q, Gao S and He J: Elevated heterogeneous nuclear ribonucleoprotein C expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma. Front Oncol. 10(598437)2020.PubMed/NCBI View Article : Google Scholar | |
|
Yan M, Sun L, Li J, Yu H, Lin H, Yu T, Zhao F, Zhu M, Liu L, Geng Q, et al: RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer. J Exp Clin Cancer Res. 38(478)2019.PubMed/NCBI View Article : Google Scholar | |
|
Guo W, Huai Q, Wan H, Guo L, Song P, Gao S and He J: Prognostic impact of IGF2BP3 expression in patients with surgically resected lung adenocarcinoma. DNA Cell Biol. 40:316–331. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Miller K, Nogueira L, Mariotto A, Rowland J, Yabroff K, Alfano C, Jemal A, Kramer J and Siegel R: Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 69:363–385. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Sun L, Liu W, Du X, Liu X, Li G, Yao Y, Han T, Li W and Gu J: Large-scale transcriptome analysis identified RNA methylation regulators as novel prognostic signatures for lung adenocarcinoma. Ann Transl Med. 8(751)2020.PubMed/NCBI View Article : Google Scholar | |
|
Xu F, Zhang H, Chen J, Lin L and Chen Y: Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma. Int Immunopharmacol. 81(105932)2020.PubMed/NCBI View Article : Google Scholar | |
|
Xu F, Chen J, Yang X, Hong X, Li Z, Lin L and Chen Y: Analysis of lung adenocarcinoma subtypes based on immune signatures identifies clinical implications for cancer therapy. Mol Ther Oncolytics. 17:241–249. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Mu X, Zhao Q, Chen W, Zhao Y, Yan Q, Peng R, Zhu J, Yang C, Lan K, Gu X and Wang Y: IL-37 confers anti-tumor activity by regulation of m6A methylation. Front Oncol. 10(526866)2020.PubMed/NCBI View Article : Google Scholar | |
|
Yu L, Kim HJ, Park MK, Byun HJ, Kim EJ, Kim B, Nguyen MT, Kim JH, Kang GJ, Lee H, et al: Ethacrynic acid, a loop diuretic, suppresses epithelial-mesenchymal transition of A549 lung cancer cells via blocking of NDP-induced WNT signaling. Biochem Pharmacol. 183(114339)2020.PubMed/NCBI View Article : Google Scholar | |
|
Li J, Chen F, Peng Y, Lv Z, Lin X, Chen Z and Wang H: N6-methyladenosine regulates the expression and secretion of TGFβ1 to affect the epithelial-mesenchymal transition of cancer cells. Cells. 9(296)2020.PubMed/NCBI View Article : Google Scholar | |
|
Gu C, Shi X, Dai C, Shen F, Rocco G, Chen J, Huang Z, Chen C, He C, Huang T, et al: RNA m6A modification in cancers: Molecular mechanisms and potential clinical applications. Innovation. 1(100066)2020. | |
|
Frye M, Harada B, Behm M and He C: RNA modifications modulate gene expression during development. Science. 361:1346–1349. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Modjtahedi H and Essapen S: Epidermal growth factor receptor inhibitors in cancer treatment: Advances, challenges and opportunities. Anticancer Drugs. 20:851–855. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Bu T, Wang C, Jin H, Meng Q, Huo X, Sun H, Sun P, Wu J, Ma X, Liu Z and Liu K: Organic anion transporters and PI3K-AKT-mTOR pathway mediate the synergistic anticancer effect of pemetrexed and rhein. J Cell Physiol. 235:3309–3319. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu S, Li Q, Li G, Zhang Q, Zhuo L, Han X, Zhang M, Chen X, Pan T, Yan L, et al: The mechanism of m6A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene. Cell Death Dis. 11(969)2020.PubMed/NCBI View Article : Google Scholar | |
|
Meng Q, Wang S, Zhou S, Liu H, Ma X, Zhou X, Liu H, Xu C and Jiang W: Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer. Pharmacogenomics J. 20:227–234. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Brown JA, Kinzig CG, DeGregorio SJ and Steitz JA: Methyltransferase-like protein 16 binds the 3'-terminal triple helix of MALAT1 long noncoding RNA. Proc Natl Acad Sci USA. 113:14013–14018. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Fish L, Navickas A, Culbertson B, Xu Y, Nguyen HCB, Zhang S, Hochman M, Okimoto R, Dill BD, Molina H, et al: Nuclear TARBP2 drives oncogenic dysregulation of RNA splicing and decay. Mol Cell. 75:967–981.e9. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Kwon J, Jo Y, Namgoong S and Kim N: Functional roles of hnRNPA2/B1 regulated by METTL3 in mammalian embryonic development. Sci Rep. 9(8640)2019.PubMed/NCBI View Article : Google Scholar | |
|
Xuan Y, Wang J, Ban L, Lu JJ, Yi C, Li Z, Yu W, Li M, Xu T, Yang W, et al: hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers. Mol Oncol. 10:610–624. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Shetty S: Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells. Mol Cell Biochem. 272:107–118. 2005.PubMed/NCBI View Article : Google Scholar |
